With the ADC oncology landscape maturing across number of programs, candidate progression, and approvals to early-line patient therapies, attention is turning to applications outside of cancer, catalyzed by advances in ADC platform technologies and unexplored medial need.

Don’t miss this workshop exploring the depth and breadth of ADCs outside of oncology to discuss transferable learnings, new hurdles, and potential of bringing improved outcomes to wider patient populations.

Workshop highlights include:

• Delving into early ADC development into indications beyond oncology: Autoimmune diseases, immunology, and beyond
• Exploring the potential of ADCs and conjugates therapies to improve safety profile against existing treatments
• Understanding different approaches to AOC development in chronic indications versus principles from oncology